MedTrace Logo

Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging

NCT00592982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-10-25

No results posted yet for this study

Summary

1. Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET).
2. Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PET imaging.

Conditions

  • Bisphosphonate-associated ONJ
  • Osteomyelitis of the Jaw
  • Osteolytic Lesions of the Jaw
  • Osteoradionecrosis of the Jaw

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Brendan Stack, MD · University of Arkansas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592982 on ClinicalTrials.gov